Member Info for sir_digby

A DHSC care facility had 1 patient admitted from hospital for convalescence who hadn't been tested in late August. Result, 26 of 28 staff infected and all 25 residents with some hospitalisations. Sequencing showed it was BQ1 likely acquired in hospital. The discharging hospital claimed they had tested the patient before transfer, subsequent investigation found they hadn't. It resulted in the facility being closed for two weeks, blocking hospital discharges.

We're barely in October and covid admissions are where they were in mid December 2021.

All fans traveling to the world cup in Qatar will require a negative test before flying there in November, regardless of vaccination status (under 6yr olds exempt).

Take a look at Coffey's voting record and views on gay marriage etc. It's unsurprising that she wouldn't be interested in vaccines for a disease that has predominantly spread around gay men in the west. Cases in over 110 countries, it will go under the radar for a little while then there'll be a resurgence when authorities and individuals take their eye off the ball.

The LTIP vested before he bought the shares therefore the November purchase had no impact on whether he got the bonus or not. How many times does this have to be pointed out?

He bought £30k worth in May 20, a sum hardly likely to propel the sp to £10 before the vestment date.

Call the clown out for things he actually didn't/did do.

@harchris, I listened to most of the presentation in the beach carpark so missed a few bits in the middle. Tentatively, there does seem to be a bit of momentum now but 2022 is an absolute write off for now, in no small part imo due to Mullis leaving a flaming bag of dog sh@t on ncyts doorstep and Allmond in his attempts to stamp it out ending up dragging it around the house for 100 days.

The money's there but a statement of intent is needed by actually spending some of it on something tangible that we and the market can see. Perversely as we both know, spend that money wisely and we could get to 100m revenue without going down an excruciating wholly organic route. They've got to start behaving as though the money is ours though, that will trump any 'strong' declarations for me, short of a dispute resolution.

The tenor I got from the presentation is he knows he has nowhere to hide from now on, this year has been callamitous and he knows it. He frequently made reference to 'shareholder value' because there will have been hundreds of questions aimed at addressing the abysmal SP performance and he really should have addressed it head on, showing a set of balls instead of skirting it.

Looks like Mullis f@cked off without any plan whatsoever and this was the inevitable result.

IVDR looks to be suffering from the same bureaucratic log jams as CDTA in the UK so the Clonit deal will allow the company to circumnvent that minefield while developing new products. To be fair this will not have been apparent until recently as the delays started to mount up so I'll credit them for taking action there and getting a deal done.

It's good to see that coprep is being opened up beyond promate, why they didn't plan for this from the start baffles me.

The company are very keen to get winterplex accredited and it seems once again UKHSA are dragging their heels, when I checked last week, not a single covid assay or lft submitted by anyone had been accredited since July which is absolutely shambolic. There's no hiding the fact that covid hospitalisations are now rising significantly in the UK and it looks like we're going to have to deal with H3N2 flu as well, I don't believe they'll have factored in any covid revenue into Q4 so there may be a boost to their pitiful guidance, we're not going to avoid a winter wave more likely two. Europe will likely fair the same.

He made particular reference to Exsig passing CDTA, referring to it as clinically validating the product. So the DHSC trialled, validated and accredited the product supplied under contract on their terms yet still had a problem, they're going to have a job on their hands convincing a judge without some damning evidence imo. If that evidence had existed the companys lawyers would already have possession of it and the company would have changed it's stance, they haven't so that's a crumb of comfort.

I think there's an acquisition being worked on but they seem keen not to divulge anything, he just seemed to be at pains to point out that they were 'doing something' so he knows he's going to have to deliver something.

Personally I'm sick of the excuses that they've trotted out this year and yeah while some of it was beyond their control he either antes up or this will be the end of his CEO aspirations because what I've seen from him thus far has been sh@t and the industry will be watching taking notes.

I think today he was genuinely trying to be enthusiastic but after their performance in the last 18 months it's a deservedly tough audience he's playing to.

Put up or shut up David because you're all out of excuses. Yours to own now.

If the IVDR pipeline is going to be around 2 years, then on the face of the clonit deal is decent business.

IMC recordings are usually available 24-48hrs after the event.

I very much doubt this rise is anything to do with the theradiag/biosynex situation. Bio don't hold enough of NCYT to influence the lunch order nevermind a buy out and most people would be smart enough to see that.

No idea otherwise but 4.5% of the company changed hands, perhaps just massively oversold or an institution willing to take a calculated risk. Just happy to see a significant bounce and hold.

Considering the macro environment in the UK, there would never be a better time for the DHSC to bury a settlement while bigger things are playing out, now that's grasping at straws.

@john2015, go to the NHS website and look for walk-in centres (use the search term grab a jab), you may come up with something closer, you can also filter for sites suitable for those with mobility issues. Availability in the south west was a huge issue last year as well. Hope this helps.

We're on our 4th secretary of health since the dispute was raised. The DHSC is in turmoil, rudderless.

Covid, even at these levels is impacting care provision at care facilities which in turn is blocking the discharge of patients from hospitals into them. Will this impact NCYT, who knows but one thing is certain I'd avoid a stretch in hospital this winter because it's going to be a mess.

Booster uptake both here and in the US is abysmal (1.5% in the US (4.5m doses) and only 20% of over 75s in the UK). I don't foresee high uptake across the board for over 50s.

Cases up, hospitalisations up and ventilators up within a couple of weeks of the DHSC removing most testing. What's this now the sixth exit wave?

Seems the virus didn't get Bidens memo, an autumn wave beckons for Europe.

https://t.co/mADe4Rn7KP

The French bourse generally leads the price, volume in France is almost 3 times that of aim today which is reflective of the shareholder split. It's been explained many times.

The same DHSC which moved heaven and earth to strip government labs so they could equip a foreign company with NO previous expertise in diagnostics resulting in them being awarded contracts worth 100s of millions. Great having a Tory mp on your board innit.

Your post was unambiguous suggesting existing directors are accused of fraud, they aren't.

If you're suspicious of my motives, fill your boots I could give a shiny sh@t. I've been excuriating about the management, I'm just not foolish enough to make posts that would put both me and lse in jeopardy of legal action.

I note your post has been removed , seems LSE didn't fancy getting sued either.

They aren't serving directors of NCYT nor have they been accused of fraud in any official capacity involving their activities while serving as directors of NCYT, no current directors have been accused of fraud either which was the thrust of your post.

You are coming very close to and have likely strayed over the line of libel, if you think they're inept then cool crack on but you've made this accusation more than once without any evidence to back it up. Simply hiding behind a username and a VPN is no guarantee of protection from action by board members.

Fraud would be a criminal matter, which NCYT board members are accused of fraud?

The company should start by updating the market with what is now in the public domain with regard to the dispute, many shareholders are not 'plugged in' to social media. Their silence on this matter is imo walking a fine line of being delinquent in their fiduciary duty.

If they were to recover the moneys owed by the DHSC we'd have around £160m cash which would allow them to acquire well in excess of £100m revenue PA on top of any organic growth (I know it seems laughable but you've got to hope he's not utterly inept). 150p would imply a MCap of £100m, far too low in this sector if you assume double digit ebitda, either that or all of our peers are massively overvalued.

What's further infuriating is the launch of products with absolutely no notification to the market, he claims to have a plan and we have no idea whether that plan is being executed.

Without a significant institutional holder there is no way to hold this board to account, Allmonds first 10 months have been a disaster for shareholders and achieving their own LTIP targets are a distant dream. The CFO himself has overseen a 90% fall in the share price, in most other listed companies he'd have already been handed his cards as a sacrificial lamb.

I'm still awaiting a response from the company with regard to who authorised the purchase of £30m worth of assays for a contract that wasn't watertight, subsequently written off and not pursued as part of the dispute. As it stands, half our bloody MCap and a gross waste of shareholders funds. That alone would have sank many of our peers.

Randox didn't need to with Patterson in their pocket, it's like having a direct line to God.

Pretty much everyone on that list including the likes Abbott and thermofisher.

@wbafc, 3 of the scenarios you've proposed would require significantly more than 25% of shareholders to vote for that. We can't even get quorate for an AGM at first time of asking. Not going to happen without someone effectively buying control of the company.

We're in this position largely because Turkey's voted for Xmas at the last 2 AGMs. When is Wakefield up for re election to the board?